WASHINGTON (dpa-AFX) - Alexion Pharmaceuticals, Inc. (ALXN), whose durg Soliris treats two rare diseases, Wednesday said it is promoting David Hallal to the newly created position of chief operating officer.
Hallal, who joined the company in 2006, was previously its executive vice president and chief commercial officer. He led the launch of Soliris. Before Alexion, he was worked at Biogen Idec and Amgen.
The company also promoted two members of the management to executive vice president from vice president: Chief Human Resources Officer Clair Carmichael ; and General Counsel John Moriarty.
The company further said it appointed Edward Miller to the nearly created position of Senior Vice President and Chief Compliance Officer.
Copyright RTT News/dpa-AFX